Professor Steve Wesselingh is SAHMRI’s inaugural Executive Director. Previously he was Dean of the Faculty of Medicine, Nursing and Health Sciences at Monash University, one of Australia’s leading health Faculties. Prior to taking up the Deanship, he was Director of the Burnet Institute, an independent medical research institute that specialises in infectious diseases, immunology and public health.

His undergraduate and doctoral training was at Flinders University and Medical Centre and his post-doctoral training was completed at Johns Hopkins Medicine in the United States.

Professor Wesselingh is an Infectious Diseases Physician with research interests in Neurovirology, HIV and vaccine development.

He has consistently worked towards the integration of high quality medical research with health-care delivery, leading to improved health outcomes for Australia and the poorly resourced countries of the region.

Highlight publications

Published In

Gargett T, Grubor-Bauk B, Miller D, Garrod T, Yu S, Wesselingh S, Suhrbier A, Gowans EJ.

Increase in DNA vaccine efficacy by virosome delivery and co-expression of a cytolytic protein.

Clin Transl Immunology. 2014 Jun 27;3(6):e18. doi: 10.1038/cti.2014.13. eCollection 2014.

Lu HK, Gray LR, Wightman F, Ellenberg P, Khoury G, Cheng WJ, Mota TM, Wesselingh S, Gorry PR, Cameron PU, Churchill MJ, Lewin SR.

Ex vivo response to histone deacetylase (HDAC) inhibitors of the HIV long terminal repeat (LTR) derived from HIV-infected patients on antiretroviral therapy.

PLoS One. 2014 Nov 19;9(11):e113341. doi: 10.1371/journal.pone.0113341. eCollection 2014.

Garrod TJ, Grubor-Bauk B, Gargett T, Li Y, Miller DS, Yu W, Major L, Burrell CJ, Wesselingh S, Suhrbier A, Gowans EJ.

DNA vaccines encoding membrane-bound or secreted forms of heat shock protein 70 exhibit improved potency.

Eur J Immunol. 2014 Jul;44(7):1992-2002. doi: 10.1002/eji.201343983. Epub 2014 May 11.

Gargett T, Grubor-Bauk B, Garrod TJ, Yu W, Miller D, Major L, Wesselingh S, Suhrbier A, Gowans EJ.

Induction of antigen-positive cell death by the expression of perforin, but not DTa, from a DNA vaccine enhances the immune response.

Clin Transl Immunology. 2014 Jun; 3(6):e18. doi: 10.1038/cti.2014.13. Epub 2014 Jun 27.

Adli M, Kleinert S, Bonk M, Wesselingh S, Ganten D.

Science to policy: M8 Alliance invites policy makers to step in.

Lancet. 2011 Oct 22;378(9801):1447-9. doi: 10.1016/S0140-6736(11)61618-8.